FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41520211000001101: Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2905561000001110 Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2905571000001117 Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Subcutaneous route true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Has specific active ingredient Mepolizumab true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Is a Mepolizumab true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninjection.subcutaneous ontology form and route true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nucala 40mg/0.4ml solution for injection pre-filled syringes (GlaxoSmithKline UK Ltd) Is a True Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has VMP True Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start